RankAlpha logo
Back to Rankings

NMRA

Neumora TherapeuticsA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
NMRA vs peer average
84/100
NMRA vs. peer average (A vs. C)
Grade spread
A 2 · C 2 · D 3 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

TRDA is the first available peer comparator.

Market-cap and clinical-stage biotechnology comparator from the supplied peer set; useful mainly for pipeline-event and financing sensitivity because direct indication or mechanism overlap is not established.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerTRDAEntrada Therapeutics
NMRA
Neumora Therapeutics
TRDA
Entrada Therapeutics
Grade
A
C
Momentum
98
13
Value
41
41
Sentiment
86
73
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs TRDA

NMRA / TRDA
Grade Position
Above peers
NMRA vs. peer average (A vs. C)
84/100
Momentum
98
NMRA
Value
41
NMRA
Sentiment
86
NMRA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs NMRA
1
TRDA
TRDA
C
60/100
+2
2
ELDN
ELDN
F
20/100
+4
3
SRZN
SRZN
A
100/100
Even
4
ANIK
Anika Therapeutics Inc Common
C
60/100
+2
5
MYGN
Myriad Genetics Inc Common
D
40/100
+3
TRDA is the first peer returned for this comparison set.